Early research suggests that monoclonal antibodies—used to protect the vulnerable from COVID-19—may provide non-addictive, long-lasting pain relief from a variety of conditions.
— Read on www.nationalgeographic.com/magazine/article/could-this-be-the-solution-to-chronic-pain-opioid-crisis-monoclonal-antibody